-
JPMorgan Lifts Gilead Sciences, Inc. (GILD)’s Price Target To $145, Maintains Overweight Rating
26 Sep 2025 14:57 GMT
Gilead Sciences, Inc. (NASDAQ:GILD) is … Overweight rating for its shares. JPMorgan Lifts Gilead Sciences, Inc. (GILD)… a 29% upside potential for Gilead Sciences, Inc. (NASDAQ:GILD) from … with a consensus Buy rating. Gilead Sciences, Inc. (NASDAQ:GILD) is …
-
Major pharma shares tanks after President Donald Trump announced 100% tariffs on imported branded medications
26 Sep 2025 20:48 GMT
Major drug company shares declined Friday after President Donald … & Johnson, Eli Lilly, Merck, Gilead Sciences, Roche, GSK, AstraZeneca, and Novo …
-
Lupin shares rise 2% on US FDA approval for HIV drug; stock up 12 times in 15 sessions
25 Sep 2025 08:10 GMT
Shares of Lupin Ltd rose 2 … ,” Lupin said.
On Thursday, Lupin shares climbed as much as 2 … mg), marketed by US-based Gilead Sciences Inc, and is indicated for …
-
Lupin shares gain 2% after USFDA approval for HIV drug
25 Sep 2025 04:34 GMT
Shares of Lupin rose 2.2% … mg) — a generic version of Gilead Sciences’ Biktarvy. The tablets are used … ,000 professionals.
On Wednesday, the shares of Lupin closed 0.72% …
-
Lupin shares edge higher after tentative US FDA approval for HIV drug generic
25 Sep 2025 04:14 GMT
Shares of Lupin Ltd edged up … equivalent of Biktarvy tablets from Gilead Sciences Inc, prescribed for the treatment … the treatment of multiple myeloma.
Shares of Lupin have been trending …
-
Goldman Sachs Sees 4 Rate Cuts by Next Summer: 5 High-Yield Dividend Winners
26 Sep 2025 20:18 GMT
… Sachs price target for the shares is $40.
Duke Energy
Duke … , Bayer, Eisai, Ridgeback Biotherapeutics, and Gilead Sciences to jointly develop and commercialize …
-
Cystic Fibrosis Therapeutics Market Size to Attain USD 39.15 Billion at 14.24% CAGR by 2034
26 Sep 2025 14:30 GMT
… .
Carbon Sciences
Enterprise Therapeutics Ltd.
Gilead Sciences
Glox Therapeutics
Novartis AG
ReCode … -wise market breakdowns, regional performance shares, detailed company profiles, annual updates …
-
Barron’s 400 ETF Rebalance Expands Exposure to Health Care and Materials While Cutting Back on Consumer Staples
25 Sep 2025 23:11 GMT
… (GE), Merck (MRK), Caterpillar (CAT), Gilead Sciences (GILD), Micron (MU) and Applied … the prospectus carefully before investing.
Shares of ETFs are bought and …
-
Gilead Foundation Grants $6.5 Million in Commitment to STEM Education
25 Sep 2025 17:30 GMT
… the accompanying tables. About Gilead Sciences Gilead Sciences, Inc. is a … business, including the following: GILEAD ® , Gilead Sciences ® , KITE TM , AMBISOME ® , ATRIPLA … 247 shares of common stock issued and outstanding, respectively.
Gilead Sciences, …
-
Lupin Gains On FDA Nod For HIV Drug; Technicals Suggest Potential Upside Above ₹2,060
25 Sep 2025 13:26 GMT
Lupin shares climbed on Thursday after the … mg tablet that matches Biktarvy, Gilead Sciences’ blockbuster drug widely used in …
About
© 1995-2025